UBS AM’s Proterra Inc. Common Stock PTRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-152,460
Closed -$232K 2730
2023
Q2
$232K Hold
152,460
﹤0.01% 2540
2023
Q1
$232K Sell
152,460
-50,096
-25% -$188K ﹤0.01% 2540
2022
Q4
$764K Buy
202,556
+39,294
+24% +$208K ﹤0.01% 1988
2022
Q3
$813K Sell
163,262
-17,099
-9% -$95.9K ﹤0.01% 2092
2022
Q2
$837K Buy
180,361
+22,000
+14% +$135K ﹤0.01% 2067
2022
Q1
$1.19M Buy
158,361
+33,898
+27% +$275K ﹤0.01% 2041
2021
Q4
$1.1M Buy
+124,463
New +$1.27M ﹤0.01% 2161

Other funds holding PTRA

UBS AM's PTRA Position: Q3 2023 in Review

UBS AM sold out of Proterra Inc. Common Stock (PTRA) in Q3 2023, closing a stake of 152,460 shares — an estimated $232K sold.

UBS AM first reported a position in PTRA in Q4 2021 and held it in 7 quarters. The position peaked at $1.19M in Q1 2022. 7 funds tracked by Wall St. Rank hold PTRA as of Q3 2023.

  • UBS AM reported no remaining Proterra Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • UBS AM sold 152,460 Proterra Inc. Common Stock shares in Q3 2023, an estimated $232K.
  • UBS AM first reported a position in Proterra Inc. Common Stock in Q4 2021 and held it in 7 quarters.
  • UBS AM's Proterra Inc. Common Stock position peaked at $1.19M in Q1 2022.
  • 7 funds tracked by Wall St. Rank held Proterra Inc. Common Stock as of Q3 2023.

Based on UBS AM's 13F filing for Q3 2023, filed 13 Nov 2023.